Company: DDC
Filing Date: 2025-07-22
Form Type: F-3
Source: 0001213900-25-066338
Chunk: 6

Company: DDC Enterprise Ltd
Filing Date: 2025-07-22
Form: F-3
Chunk 6
---
 Appropriations
Act”), was signed into law by President Biden. The Consolidated Appropriations Act contained, among other things, an identical provision
to AHFCAA, which reduces the number of consecutive non-inspection years required for triggering the prohibitions under the Holding Foreign
Companies Accountable Act from three years to two. Whether the PCAOB will continue to be able to satisfactorily conduct inspections of
PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong is subject to uncertainty and depends on a number
of factors out of our, and our auditor’s, control. The PCAOB is continuing to demand complete access in mainland China and Hong
Kong moving forward and is already making plans to resume regular inspections in early 2023 and beyond, as well as to continue pursuing
ongoing investigations and initiate new investigations as needed. The PCAOB has indicated that it will act immediately to consider the
need to issue new determinations with the HFCAA if needed, without having to wait another year to reassess its determinations. In the
future, if there is any regulatory change or step taken by PRC regulators that does not permit our auditor to provide audit documentations
located in China or Hong Kong to the PCAOB for inspection or investigation, or the PCAOB expands the scope of the determination so that
we are subject to the HFCAA, as the same may be amended, you may be deprived of the benefits of such inspection which could result in
limitation or restriction to our access to the U.S. capital markets and trading of our securities, including trading on the national exchange
and trading on “over-the-counter” markets, may be prohibited under the HFCAA.

You should read carefully this prospectus and the
documents incorporated by reference into this prospectus before investment.

Investing in our securities involves a high degree of risk. See “Risk Factors” in this prospectus and in the documents incorporated by reference in this prospectus, as updated in the applicable prospectus supplement, any related free writing prospectus and other future filings we make with the Securities and Exchange Commission that are incorporated by reference into this prospectus, for a discussion of the factors you should consider carefully before deciding to purchase our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is [●], 2025